hims hers stock - Search News

Hims, Hers

Barron's on MSN · 1h

Hims & Hers Stock Tumbles Despite Beating Expectations

Hims & Hers Health shares tumbled despite the telehealth provider beating fourth-quarter expectations and offering better-than-expected revenue forecasts for the first quarter and 2025.For the full year 2025,

HIMS Earnings Preview: Will The Stock Rebound After 25% Drop?

Hims & Hers Health (NYSE:HIMS) is set to report its earnings on Monday, Feb 24 after market close. HIMS stock plunged over 25% on Friday, Feb 21, after the U.S. FDA announced semaglutide is no longer in shortage.

MarketWatch · 16h

Hims & Hers Shares Sink Despite Upbeat Earnings, Outlook

Shares of Hims & Hers Health fell, dragged down by expectations that the telehealth-consultation platform will have to stop selling its weight-loss treatments, which boosted results in the fourth quarter.

Modern Healthcare · 21h

Hims & Hers stock rally stalls as earnings call looms

On Friday, the Food and Drug Administration declared the semaglutide shortage over, sending Hims & Hers shares down 26%.

Hims, Novo Nordisk and Weight loss

MarketWatch on MSN · 57m

Novo Nordisk’s stock is rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.

Wall Street Journal · 25m

Novo Nordisk Stock Rallies on Weight-Loss Retreat by Hims & Hers

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood about 17% lower at under $42.

Markets Insider on MSN · 6h

Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop making copies.

12h

Hims & Hers offers upbeat forecast, but stock slides after hours

Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s ...

45mon MSN

These Stocks Are Moving the Most Today: Super Micro, Nvidia, Home Depot, Palantir, Hims & Hers, MicroStrategy, PayPal, and More

Super Micro has until Tuesday to file delayed financial accounts or risk being delisted by the Nasdaq stock exchange, ...

2h

Hims & Hers: Capitalizing On The GLP-1 Rush Before The Window Closes (Rating Upgrade)

Hims & Hers projects $725M in GLP-1 weight loss revenue for 2025, a 3.2x increase from 2024. Read why I upgrade HIMS stock ...

4don MSN

Why Hims & Hers Stock Dropped Today

Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) ...

3don MSN

Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

5h

Hims & Hers Earnings: Very Strong Business, In A Very Crowded Trade

Hims & Hers delivered Q4 2024 earnings that saw the stock sell off nearly 20% after hours. Find out why I rate HIMS stock a ...

3don MSN

Why Hims & Hers Health Stock Is Plummeting Today

Shares of Hims & Hers Health ( HIMS -25.79%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results